![Angela Cacace](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Angela Cacace
Directeur Technique/Scientifique/R&D chez
ARVINAS, INC.
Fortune : 1 M $ au 30/06/2026
Profil
Dr. Angela Cacace is a Chief Scientific Officer at Arvinas, Inc. Dr. Cacace was previously employed as a Neuroscience Director by Bristol Myers Squibb Co. She received her undergraduate degree from Fairfield University and a doctorate degree from The Trustees of Columbia University in The City of New York.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ARVINAS, INC. 0,28% | 17/06/2026 | 180 390 ( 0,28% ) | 1 M $ | 30/06/2026 |
Postes actifs de Angela Cacace
| Sociétés | Poste | Début |
|---|---|---|
| ARVINAS, INC. | Directeur Technique/Scientifique/R&D | 17/06/2024 |
Anciens postes connus de Angela Cacace
| Sociétés | Poste | Fin |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Formation de Angela Cacace
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
33
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fairfield University
 Fairfield University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arvinas, Inc.
 Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
